Windtree Therapeutics, Inc.
WINT
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.76% | -169.27% | 91.19% | 60.90% | 53.46% |
| Total Depreciation and Amortization | -45.45% | -331.25% | -320.73% | -122.65% | -143.42% |
| Total Amortization of Deferred Charges | -263.33% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.68% | 95.68% | -414.72% | -164.31% | -146.13% |
| Change in Net Operating Assets | -71.72% | -34.30% | -32.06% | 413.33% | 533.12% |
| Cash from Operations | -19.69% | -7.19% | -14.62% | -15.35% | 5.94% |
| Capital Expenditure | 100.00% | 20.00% | 20.00% | 20.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19,096.30% | 20.00% | 20.00% | 20.00% | -- |
| Total Debt Issued | 366.06% | -- | -- | -- | -- |
| Total Debt Repaid | -115.00% | 5.14% | -1.00% | 1.28% | 35.48% |
| Issuance of Common Stock | 637.04% | 17.68% | 15.21% | -20.65% | -85.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 159.52% | 132.00% | -- | -- | -- |
| Cash from Financing | 547.29% | 12.14% | 9.81% | -17.23% | -78.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.69% | 25.41% | -44.37% | -384.28% | -11,635.29% |